Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 31, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 3, 2026
OfficerIndirect holdingOther
Context
Classification
other
Code I — not an open-market trade
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001225208-26-006881
Filed / recorded
Aug 3, 2026, 8:29 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
BOSTON SCIENTIFIC CORP
Issuer CIK
885725
Ticker
BSX
Reporting person
Joseph Michael Fitzgerald
Relationship
Officer
Officer title
EVP & Group Pres, Cardiology
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Jul 31, 2026
Transaction code
I
Shares / units
64,198
Price per share
$46.73
Acquired / disposed
Acquired (A)
Shares owned after
64,198
Ownership form
Indirect — By 401(k)
Amendment
No
Footnotes from the filing
Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.
Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
A board member of Boston Scientific spent $100K of their very own money to buy Boston Scientific shares. 3 other people at Boston Scientific bought some too, in the same month. Their pile of Boston Scientific shares grew by 17%.
